o NoneEntity Type
0001292519
Design Source, Inc.
 
x Corporation
o Limited Partnership
o Limited Liability Company
o General Partnership
o Business Trust
o Other
Name of Issuer
 INVIVO THERAPEUTICS HOLDINGS CORP.
Jurisdiction of Incorporation/OrganizationNEVADA 
Year of Incorporation/Organization
  x Over Five Years Ago
  o Within Last Five Years (Specify Year)  
  o Yet to Be Formed 



2. Principal Place of Business and Contact Information
Name of Issuer 
 INVIVO THERAPEUTICS HOLDINGS CORP. 
Street Address 1Street Address 2
 ONE KENDALL SQUARE Suite B14402
CityState/Province/CountryZIP/Postal CodePhone No. of Issuer
 CAMBRIDGE MASSACHUSETTS 02139 617-863-5524 



3. Related Persons
Last NameFirst NameMiddle Name
ToselliRichard
Street Address 1Street Address 2
One Kendall SquareSuite B14402
CityState/Province/CountryZIP/Postal Code
CambridgeMASSACHUSETTS02139
Relationship: x Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
  

Last NameFirst NameMiddle Name
ChristopherRichard
Street Address 1Street Address 2
One Kendall SquareSuite B14402
CityState/Province/CountryZIP/Postal Code
CambridgeMASSACHUSETTS02139
Relationship: x Executive Officer o Director o Promoter
Clarification of Response (if Necessary)
  

Last NameFirst NameMiddle Name
MerrifieldC.Ann
Street Address 1Street Address 2
One Kendall SquareSuite B14402
CityState/Province/CountryZIP/Postal Code
CambridgeMASSACHUSETTS02139
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
  

Last NameFirst NameMiddle Name
MarshakDaniel
Street Address 1Street Address 2
One Kendall SquareSuite B14402
CityState/Province/CountryZIP/Postal Code
CambridgeMASSACHUSETTS02139
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
  

 
Last NameFirst NameMiddle Name
MorrisonChristina
Street Address 1Street Address 2
One Kendall SquareSuite B14402
CityState/Province/CountryZIP/Postal Code
CambridgeMASSACHUSETTS02139
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
  

Last NameFirst NameMiddle Name
RobertsRichard
Street Address 1Street Address 2
One Kendall SquareSuite B14402
CityState/Province/CountryZIP/Postal Code
CambridgeMASSACHUSETTS02139
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
  

Last NameFirst NameMiddle Name
RosenthalRobert
Street Address 1Street Address 2
One Kendall SquareSuite B14402
CityState/Province/CountryZIP/Postal Code
CambridgeMASSACHUSETTS02139
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
  

 


4. Industry Group
o Agriculture Health Care o Retailing
 Banking & Financial Services   x Biotechnology o Restaurants
  o Commercial Banking   o Health Insurance Technology
  o Insurance  o Hospitals & Physicians  o Computers
  o Investing  o Pharmaceuticals  o Telecommunications
  o Investment Banking  o Other Health Care  o Other Technology
  o Pooled Investment Fund

    Travel
  o Other Banking & Financial Services o Manufacturing  o Airlines & Airports
 Real Estate  o Lodging & Conventions
  o Commercial  o Tourism & Travel Services
  o Construction  o Other Travel
  o REITS & Finance o Other
  o Residential 
  o Other Real Estate 
o Business Services 
 Energy 
  o Coal Mining 
  o Electric Utilities 
  o Energy Conservation 
  o Environmental Services 
  o Oil & Gas 
  o Other Energy 


5. Issuer Size
Revenue RangeAggregate Net Asset Value Range
o No Revenues o No Aggregate Net Asset Value
o $1 - $1,000,000 o $1 - $5,000,000
o $1,000,001 - $5,000,000 o $5,000,001 - $25,000,000
o $5,000,001 - $25,000,000 o $25,000,001 - $50,000,000
o $25,000,001 - $100,000,000 o $50,000,001 - $100,000,000
o Over $100,000,000 o Over $100,000,000
x Decline to Disclose o Decline to Disclose
o Not Applicable o Not Applicable


6. Federal Exemption(s) and Exclusion(s) Claimed (select all that apply)
o Rule 504(b)(1) (not (i), (ii) or (iii)) o Rule 505
o Rule 504 (b)(1)(i) x Rule 506(b)
o Rule 504 (b)(1)(ii) o Rule 506(c)
o Rule 504 (b)(1)(iii) o Securities Act Section 4(a)(5)
  o Investment Company Act Section 3(c)

7. Type of Filing
x New Notice Date of First Sale 2020-04-17 o First Sale Yet to Occur
o Amendment

8. Duration of Offering
Does the Issuer intend this offering to last more than one year? o Yes x No

9. Type(s) of Securities Offered (select all that apply)
o Pooled Investment Fund Interests o Equity
o Tenant-in-Common Securities o Debt
o Mineral Property Securities x Option, Warrant or Other Right to Acquire Another Security
x Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security o Other (describe)
  


10. Business Combination Transaction
Is this offering being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer? o Yes x No
 
Clarification of Response (if Necessary) 
  

11. Minimum Investment
Minimum investment accepted from any outside investor$ 0 USD

12. Sales Compensation
RecipientRecipient CRD Number o None
 H.C. Wainwright & Co., LLC 375
(Associated) Broker or Dealer x None(Associated) Broker or Dealer CRD Number x None
    
Street Address 1Street Address 2
 430 Park Avenue 4th Floor
City State/Province/CountryZIP/Postal Code
 New York NEW YORK 10022
State(s) of Solicitation x All States o Foreign/Non-US
 

 



13. Offering and Sales Amounts
Total Offering Amount $ 3022576 USD o Indefinite
Total Amount Sold $ 3022576 USD 
Total Remaining to be Sold $ 0 USD o Indefinite
 
Clarification of Response (if Necessary)
 Private Placement of (i) warrants to purchase 1,715,240 shares of common stock at a purchase price of $1.62 per share and (ii) warrants to purchase 111,491 shares of common stock at a purchase price of $2.1875 per share


14. Investors
o Select if securities in the offering have been or may be sold to persons who do not qualify as accredited investors,
Number of such non-accredited investors who already have invested in the offering
 
  Regardless of whether securities in the offering have been or may be sold to persons who do not qualify as accredited investors, enter the total number of investors who already have invested in the offering: 8


15. Sales Commissions & Finders’ Fees Expenses
Provide separately the amounts of sales commissions and finders' fees expenses, if any. If the amount of an expenditure is not known, provide an estimate and check the box next to the amount.
Sales Commissions$ 255152 USD o Estimate
Finders' Fees$ 0 USD o Estimate
 
Clarification of Response (if Necessary)
  


16. Use of Proceeds
Provide the amount of the gross proceeds of the offering that has been or is proposed to be used for payments to any of the persons required to be named as executive officers, directors or promoters in response to Item 3 above. If the amount is unknown, provide an estimate and check the box next to the amount.
 $ 0 USD o
InVivo Therapeutics (NASDAQ:NVIV)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more InVivo Therapeutics Charts.
InVivo Therapeutics (NASDAQ:NVIV)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more InVivo Therapeutics Charts.
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No NVIV Message Board. Create One! See More Posts on NVIV Message Board See More Message Board Posts

Invivo Therapeutics Holdings Corp. News

Loading Messages....

More Invivo Therapeutics Holdings Corp. News Articles